Lynn Schenk, Director at BIOGEN IDEC INC. (BIIB), sold 37,275 shares at $85.00 ($3.2M) on 2011-04-20, disclosed to the SEC on 2011-04-21.
Scheduled sale ($3.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 27,275 | $2.3M | 73.0% |
| 2 | $85.81 | 10,000 | $858K | 27.0% |
| Total | $85.22 avg | 37,275 | $3.2M | 100% |
| Filing → |
| SRE | SELL | 2014-06-19 | $263K | — | Filing → |
| BIIB | SELL | 2014-01-16 | $297K | — | Filing → |
| BIIB | SELL | 2013-12-02 | $292K | — | Filing → |